237 related articles for article (PubMed ID: 18780825)
1. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor blood flow in breast tumors with T1-dynamic contrast-enhanced MR imaging: impact of dose reduction and the use of a prebolus technique on diagnostic efficacy.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2010 Mar; 31(3):556-61. PubMed ID: 20187197
[TBL] [Abstract][Full Text] [Related]
3. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
[TBL] [Abstract][Full Text] [Related]
4. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
[TBL] [Abstract][Full Text] [Related]
5. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
Wang Y; Ikeda DM; Narasimhan B; Longacre TA; Bleicher RJ; Pal S; Jackman RJ; Jeffrey SS
Radiology; 2008 Feb; 246(2):367-75. PubMed ID: 18180338
[TBL] [Abstract][Full Text] [Related]
7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Uematsu T; Kasami M; Yuen S
Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
[TBL] [Abstract][Full Text] [Related]
9. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
[TBL] [Abstract][Full Text] [Related]
11. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
12. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.
Bae MS; Seo M; Kim KG; Park IA; Moon WK
Acta Radiol; 2015 Mar; 56(3):269-75. PubMed ID: 24558165
[TBL] [Abstract][Full Text] [Related]
13. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
[TBL] [Abstract][Full Text] [Related]
14. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Stephan C; Taupitz M; Beyersdorff D
Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
[TBL] [Abstract][Full Text] [Related]
17. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
18. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
19. Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.
Lindström LS; Karlsson E; Wilking UM; Johansson U; Hartman J; Lidbrink EK; Hatschek T; Skoog L; Bergh J
J Clin Oncol; 2012 Jul; 30(21):2601-8. PubMed ID: 22711854
[TBL] [Abstract][Full Text] [Related]
20. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
